Serum miR-1290 as a marker of pancreatic cancer--letter.

Authors’ Affiliations: HPB Surgical Unit and Division of Oncology, both in Department of Surgery & Cancer, Imperial College, Hammersmith Hospital campus, Du Cane Road, London, W12 0HS, United Kingdom; and Departments of Surgery and Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands. Corresponding Author: Elisa Giovannetti, Department of Medical Oncology, VU University Medical Center, CCA room 1.42, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. Phone: 31-20-4442267; Fax: 31-20-4443844; E-mail: [email protected] Disclosures: The authors have no conflicts of interest to declare. No writing assistance was utilized during production of this manuscript.